Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population
Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population
复制标题
血浆 IL-36α 和 IL-36γ 作为类风湿性关节炎相关间质性肺病的潜在生物标志物:中国人群的初步研究
DOI:
10.1007/s10753-022-01733-x
复制
发表时间:
2022-08
期刊:
影响因子:
5.1
通讯作者:
Zhenshun Cheng
中科院分区:
文献类型:
--
作者:
Weishuai Zheng;Xingxing Hu;Menglin Zou;Nie Hu;Weiwei Song;Rui Wang;Ying Liu;Qinhui Hou;Yuan Liu;Xiaoqi Chen;Zhenshun Cheng
Interstitial lung disease (ILD) is a frequent extra-articular manifestation of rheumatoid arthritis (RA) and increases mortality in patients with RA. Early identification of ILD, especially the usual interstitial pneumonia (UIP) pattern with a poor prognosis, is important for guiding treatment of RA-ILD and preventing damage resulting from a delay in diagnosis. Interleukin-36 (IL-36) cytokines are involved in connective tissue diseases. However, IL-36 expression in RA-ILD is unknown. In this study, the clinical relevance of plasma IL-36 cytokines was evaluated in 39 patients with RA-ILD and three other groups (30 healthy controls 35 RA patients without ILD, and 27 patients with idiopathic pulmonary fibrosis [IPF) in the Chinese population. Plasma IL-36α and IL-36γ concentrations were elevated in patients with RA-ILD compared with those in HCs and patients with RA. RA-ILD patients with UIP pattern had higher plasma IL-36γ concentrations than those with RA-ILD without UIP, but these were lower than those in patients with IPF. Receiver operating curve analysis suggested that IL-36α and IL-36γ were potential biomarkers for identifying ILD in patients with RA. Additionally, the optimal cutoff value of IL-36γ for distinguishing RA-ILD with the UIP pattern from RA-ILD without UIP was 555.40 pg/mL and that for distinguishing RA-ILD from IPF was 655.10 pg/mL. No significant difference in plasma IL-36β or IL-36Ra concentrations was found between patients with RA-ILD and the three other groups. We also found that the lungs originating from different types of patients with PF, including RA-ILD and IPF, and those from mice following bleomycin-induced PF were characterized by increased IL-36γ expression. Our findings suggest that using IL-36 cytokines to identify patients with RA for further ILD workups may provide additional diagnostic value to the current clinically available assays. Moreover, IL-36γ may help to identify the presence of the UIP pattern in patients with RA-ILD and to discriminate RA-ILD from IPF.
登录
查看更多内容
DOI:
10.1007/978-3-540-76735-0_8
发表时间:
2009
期刊:
Molecular and Cellular Neurosciences
影响因子:
--
作者:
P. Russell
通讯作者:
P. Russell
DOI:
--
发表时间:
2010
期刊:
--
影响因子:
--
作者:
D. Aletaha;T. Neogi;A. Silman;Julia Funovits;D. Felson;C. Bingham;N. Birnbaum;G. Burmester;V. Byker
通讯作者:
D. Aletaha;T. Neogi;A. Silman;Julia Funovits;D. Felson;C. Bingham;N. Birnbaum;G. Burmester;V. Byker
影响因子:
4.6
作者:
Boutet, M. -A.;Bart, G.;Blanchard, F.
通讯作者:
Blanchard, F.
影响因子:
--
作者:
Bongartz, Tim;Nannini, Carlotta;Medina-Velasquez, Yimy F.;Achenbach, Sara J.;Crowson, Cynthia S.;Ryu, Jay H.;Vassallo, Robert;Gabriel, Sherine E.;Matteson, Eric L.
通讯作者:
Matteson, Eric L.
影响因子:
5.6
作者:
Melton E;Qiu H
通讯作者:
Qiu H